Lysophosphatidic acid (LPA; 1-acyl-sn-glycerol-3-phosphate), an abundant constituent of serum, mediates multiple biological responses via G protein-coupled serpentine receptors. Schwann cells express the LPA receptors (Edg receptors), which, once activated, have the potential to signal through G ␣i to activate p21 ras and phosphatidylinositol 3-kinase, through G ␣q to activate phospholipase C, or through G q12/13 to activate the Rho pathway. We found that the addition of serum or LPA to serum-starved Schwann cells rapidly (10 min) induced the appearance of actin stress fibers via a Rho-mediated pathway. Furthermore, LPA was able to rescue
In the peripheral nervous system, Schwann cells (SCs) 1 form the myelin sheath and play a key role in the maintenance of the normal physiological function of the axon (1) . The majority of SCs originate from neural crest cells under the guidance of axonal cues that regulate the proliferation, survival, and differentiation of precursor cells into myelin-forming cells (1) . During differentiation, SCs make contact with a single axon, become spindle-shaped, and then form a myelin sheath that contains specific proteins such as myelin P 0 protein (2) . The survival and differentiation of SCs are regulated by extracellular cues from axons and the extracellular matrix (3) (4) (5) (6) . Some of these factors are lysophosphatidic acid (LPA), ␤-neuregulin, and insulin-like growth factor-I for SC survival; ␤-neuregulin, platelet-derived growth factor, epidermal growth factor, and tumor growth factor-␤ for SC proliferation; and tumor growth factor-␤ and jagged/delta for regulating myelin gene expression (7) (8) (9) (10) (11) . The factors that regulate SC survival do so through activation of Akt and MAPK signaling pathways, whereas actin reorganization is regulated through the Rho family of GTPase (12, 13) . Additionally, agents that elevate intracellular cAMP levels stimulate myelin gene expression (10, 14) . However, aside from the effects of cAMP on myelin gene expression, there is little information on the signaling pathways involved in regulating myelin gene expression.
All peripheral nerves have a blood-nerve barrier that normally excludes large molecules contained in serum from entering the endoneurial space where SCs reside (15) . In some pathological states, this barrier is broken, resulting in the entry of serum into the endoneurial space. Whereas serum promotes SC survival, it also down-regulates myelin gene expression (16) . Interestingly, LPA, a normal constituent of serum (concentration varies between 2 and 20 M), replicates many of the cellular effects of serum that include effects on SC survival (7) and actin rearrangement (13) . Some of the other effects of LPA include stimulation of platelet aggregation, smooth muscle contraction, stimulation of cell proliferation (fibroblasts, smooth muscle cells, endothelial cells, and keratinocytes), differentiation (keratinocytes, neuroblastoma, and myoblasts), induction of apoptosis (neurons, T cells, and macrophages), collapse of axonal growth cones with retraction of neurites, release of neurotransmitters, inhibition of gap junction communication, induction of focal adhesions, induction of stress fibers, invasion of tumor cells, and regulation of gene expression (17) .
The effects of LPA on target cells are mediated by activation of specific G protein-coupled serpentine receptors. The first LPA receptor identified, vzg-1 (ventricular zone gene-1; also termed Edg-2/rec1.3/lp A1 ) encodes a 41-kDa protein that is widely expressed in mouse tissue with the highest levels seen in embryonic cortex (18) . In postnatal life, the LPA receptor lp A1 /vzg-1 is predominantly expressed in glial cells (mainly oligodendrocytes and SCs) (7, 19) . The appearance of the lp A1 / vzg-1/Edg-2 receptor in SCs parallels the appearance of myelin formation in developing peripheral nerves and is up-regulated after nerve injury (7, 13) . Although it is likely that lp A1 /vzg-1/ Edg2 receptor is responsible for mediating most of the effects of LPA, SCs from lp A1 Ϫ/Ϫ mice were able to respond to LPA, indicating that other LPA receptors such as lp A2 /Edg4 or lp A3 /E7 may be involved in mediating the LPA effects, since SC also expresses lp A2 /Edg4 (13).
LPA receptors are coupled to at least three different G␣ proteins: G ␣i , G ␣q , and G ␣12/13 (20, 21) . Activation of G␣ q stimulates phospholipase C activity, thereby increasing the amount of diacylglycerol and inositol 3-phosphate. Diacylglycerol, in turn, activates protein kinase C (PKC), whereas inositol 3-phosphate mobilizes intracellular calcium. LPA activation of pertussis toxin (PTX)-sensitive G␣ i decreases intracellular cAMP by inhibiting adenylyl cyclase and also induces MAPK/ extracellular signal-regulated kinase activity. LPA activation of G ␣12/13 stimulates the Rho pathway, which in turn induces serum response element-mediated transcription, actin cytoskeletal reorganization, and activation of PI3K.
Rat SCs undergo apoptosis during normal development. They also undergo apoptosis after nerve injury, in dysmyelinating disease, and during demyelination in experimental allergic neuritis. In vitro, SC apoptosis is observed after serum withdrawal (12, 22) . Serum, LPA, and ␤-neuregulin all promote SC survival. In previous studies investigating the signaling pathways responsible for LPA-and ␤-neuregulin-induced SC survival, PI3K was shown to play a pivotal role, although the relative importance of MAPK and protein kinase B (Akt) in this process is unclear (7, 12) . Moreover, LPA has been shown to induce actin rearrangement in SCs (13) . In this study, we provide evidence that LPA promotes SC survival through a signal transduction pathway involving PTX-sensitive G ␣i protein, PI3K, and MAPK. We also demonstrate that LPA, acting through receptor lp A2 /Edg4 and its downstream effector protein kinase C␦ (PKC␦), induces expression of myelin P 0 protein and that the Rho pathway regulates the actin cytoskeleton reorganization. These results suggest multiple roles for LPA in SC survival and differentiation.
EXPERIMENTAL PROCEDURES
Materials-LPA, 4␤-phorbol 12-myristate 13-acetate (PMA), pertussis toxin (inhibitor of G␣ i ), and wortmannin (PI3K inhibitor) were obtained from Sigma. PKC inhibitors, bisindolylmaleimide II and rottlerin, were obtained from Calbiochem (23) . The MEK inhibitor, PD98059, was from New England Biolabs (Beverly, MA). The PI3K inhibitor, LY294002, and PKC inhibitor, Gö6976, were obtained from Biomol (Plymouth Meeting, PA) (24) . The Rho kinase (ROCK) inhibitor, Y27632, was obtained from Yoshitomi Pharmaceutical Industries (Saitama, Japan) (25) . Rabbit antibodies against phosphorylated MAPK, total MAPK, phosphorylated Akt, and total Akt were obtained from New England Biolabs. Rabbit anti-PKC␦ antibody and goat antiEdg4 antibody were from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA). Rabbit anti-Edg2 antibody was from BIOSOURCE (Camarillo, CA). Rabbit anti-P 0 antibody was provided by Dr. Bruce Trapp (Cleveland Clinic, Cleveland, OH).
Schwann Cell Isolation-Rat Schwann cells were isolated from the sciatic nerves of 2-day-old rat pups using the method described by Brockes et al. (26) . The cells were maintained in Dulbecco's modified Eagle's medium supplemented with 10% heat-inactivated fetal bovine serum. Schwann cells were expanded using 2 M forskolin and 25 ng/ml recombinant glial growth factor (27) . Prior to all of the studies, both forskolin and glial growth factor were removed from the cell culture for 1 week.
Apoptosis Assay-To assess morphological changes in chromatin structure of SCs undergoing apoptosis, attached and floating cells were collected and centrifuged. The pellet was resuspended in 100 l of PBS (pH 7.4) containing 0.03% Nonidet P-40, 0.15 mM sodium citrate, and 0.014% propidium iodide (Sigma). Cells were examined under a fluorescent microscope at ϫ400 magnification and scored for cells with normal and condensed chromatin. The data are expressed as a percentage of the cells with condensed chromatin (apoptotic cells).
Western Blotting-After the different treatment paradigms, SCs were rinsed once with PBS and then with TBS (50 mM Tris, pH 8.0, and 150 mM NaCl). Cells were lysed in radioimmune precipitation buffer (50 mM Tris, pH 8.0, 150 mM NaCl, 1% Nonidet P-40, 0.5% deoxycholate, 0.1% SDS, 1 mM p-nitrophenyl phosphate, 20 nM calyculin A, 1 mM sodium vanadate, 1 mM phenylmethylsulfonyl fluoride, 1 g/ml leupeptin, and 10 g/ml aprotinin). The lysates were collected and clarified by centrifugation for 15 min at 4°C. Protein concentration of cell lysates was measured by BCA protein assay (Pierce). 50 g of cell lysate were then electrophoresed through an SDS-polyacrylamide gel and then transferred onto nitrocellulose membrane. The blots were then incubated overnight at 4°C with the primary antibody. The following day, the blots were incubated with horseradish peroxidase-conjugated secondary antibody (1:10,000 dilution; Amersham Biosciences) for 1 h at room temperature. Bands were visualized by the ECL Western blot detection system (Amersham Biosciences).
Transient Transfection and Chloramphenicol Acetyltransferase (CAT) Assay-SCs were transfected with 10 g of P 0 CAT reporter plasmid by the calcium phosphate precipitation technique, and exposed to the precipitate for 8 h. Cultures were washed with PBS and incubated with fresh medium. After 24 h, cells were harvested, and the protein concentration of cell lysates was measured by the BCA method (Pierce). CAT activity was determined by the conversion of [
14 C]chloramphenicol to its acetylated product (28) .
Infection of Schwann Cells with Dominant Negative PKC␦, PKC␣, and LacZ Adenoviruses-Adenovirus (AdV)-expressing dominant negative PKC␣ and PKC␦ were generated as described (29, 30) . SCs grown in 60-mm dishes were infected with dominant negative PKC␦, dominant negative PKC␣, or LacZ adenovirus for 16 h at multiplicities of infection of 300 plaque-forming units/cell in Dulbecco's modified Eagle's medium with 2% fetal bovine serum. Infection of SCs with a multiplicity of infection of 300 plaque-forming units/cell was determined in preliminary studies by maximizing for GFP-expressing cells using GFPAdV. After removal of the virus, cells were incubated in Dulbecco's modified Eagle's medium with 2% fetal bovine serum for 24 h and then treated with LPA. 24 h later, the cells were lysed in radioimmune precipitation buffer and analyzed.
Purification of Recombinant Proteins and Microinjection-Plasmid containing glutathione S-transferase-RhoA (V14) was expressed in
Escherichia coli, and the recombinant protein was purified using glutathione-Sepharose 4B beads (31) . The botulinum C3 exoenzyme was purified as described (32) . The protein concentrations of the recombinant glutathione S-transferase fusion protein and C3 transferase were determined by using the BCA protein assay kit (Pierce).
For microinjection, SCs were plated onto poly-L-lysine (0.1 g/ml; Sigma)-coated 12-mm diameter circular glass coverslips. The coverslips were scored with a diamond pen to help identify the area where the cells were microinjected. Before microinjection or specific treatment paradigms, the cells were serum-starved for 16 -20 h. Cells were visualized using a Zeiss inverted microscope, and microinjections were performed using an Eppendorf microinjector. For each experiment, proteins were injected into the cytoplasm of 100 cells, together with rabbit immunoglobulin (IgG at 4 mg/ml; Jackson Immunoresearch Laboratories) to facilitate identification of the injected cells.
Immunofluorescence Staining-SCs were fixed in 10% formalin solution for 15 min at room temperature. After several washes with PBS, the cells were permeabilized with 0.2% Triton X-100 in phosphatebuffered saline for 5 min and then blocked with 2% bovine serum albumin in PBS for 30 min. Cells were incubated with 0.2 g/ml TRITClabeled phalloidin (Sigma) and Texas Red-labeled donkey anti-rabbit IgG (Jackson Immunoresearch Laboratories) for 1 h at room temperature and viewed using a Leitz microscope.
RNA Interference-21-Nucleotide RNA duplexes with 2-nucleotide (2Ј-deoxy)thymidine 3Ј overhangs directed against nucleotides 419 -441 and 1186 -1208 of the respective rat Edg2 and mouse Edg4 coding sequences were obtained from Dharmacon Research Inc. (Lafayette, CO). GL2 luciferase small interfering RNA (siRNA) duplex was used as a nonspecific siRNA control (Dharmacon Research).
The day before transfection, cells were plated onto 60-mm dishes in fresh medium without antibiotics. Transient transfection of siRNAs was carried out using Oligofectamine (Invitrogen), following the manufacturer's instructions. Cells were treated in 200 nM siRNA transfection solution (2 ml/dish) for 4 h and then incubated in Dulbecco's modified Eagle's medium containing 10% fetal calf serum for 24 h. Cells were then treated with LPA (10 M in serum-free medium) for 24 h and harvested.
PKC␦-GFP Translocation-Cells were plated onto 35-mm glass bottom culture dishes (MarTek Corp., Ashland, MA) and transfected with a plasmid carrying a DNA insert encoding for a PKC␦-GFP fusion protein (30) using FuGENE 6 (Roche Molecular Biochemicals). Translocation of PKC␦-GFP was monitored under a confocal laser-scanning fluorescence microscope (30) .
RESULTS

LPA Is a Survival
Factor for Schwann Cells-SCs undergo apoptosis upon serum withdrawal, characterized by DNA con-densation in the nucleus (Fig. 1A) . About 50% of SCs underwent apoptosis following serum withdrawal for 24 h (Fig. 1B) . The addition of serum to the medium completely prevented apoptosis in SCs. When 10 M LPA was added to serum-starved SCs, apoptotic cells were dramatically reduced from 45 to 6% (Fig. 1B) . Since LPA is a component of serum, this finding indicates that LPA is an important constituent in serum-induced SC survival.
Since the effects of LPA are mediated via its cognate receptor, we examined the effects of different doses of LPA on its survival activity in SCs. LPA prevented SC apoptosis in a dose-dependent manner, with the antiapoptotic effect being observed at a concentration as low as 0.1 M of LPA with a maximal effect being observed at 10 M (Fig. 1C) . Based on these results, all subsequent experiments in this study were performed with 10 M of LPA.
Inhibitors of G ␣i PI-3 Kinase and MEK Prevent LPA Protection from Apoptosis-The role of the PI3K/Akt and MAPK pathways in SC survival has been demonstrated (12, 34, 35) . To evaluate the contribution of different signaling pathways in mediating LPA-induced SC survival, several specific inhibitors were used. The selection of the inhibitors used in this study was based on knowledge of the G proteins implicated in LPA signaling. Pertussis toxin, an inhibitor of G ␣i , blocked the antiapoptotic effect of LPA (Fig. 1B) , as did the PI3K inhibitors wortmannin and LY249002 (Fig. 1B) . Furthermore, inhibition of MEK by PD98059 also blocked the antiapoptotic effect of LPA (Fig. 1B) . Rapamycin, an inhibitor of mTOR that prevents activation of p70 S6 kinase, had no effect on LPA-mediated survival (Fig. 1B) . Of interest, LY249002 in the absence of LPA increased apoptosis (Fig. 1B) , probably due to the inhibition of basal PI3K activity in SCs (12) . Furthermore, neither inhibition of PKC␦ by rottlerin nor Rho kinase by Y27632 had any effect on the ability of LPA to promote SC survival (data not shown). These results indicate that the survival effect of LPA on serum-starved SCs is mediated in a G ␣i /PI3K/MEK/MAPKdependent manner.
LPA Stimulates Phosphorylation of MAPK through a PTXsensitive and PI3K-dependent Pathway-To further study the signaling pathways that mediate the survival effect of LPA, MAPK and Akt phosphorylation were measured. LPA stimulated MAPK phosphorylation (activation) in a time-dependent manner ( Fig. 2A) . Activation of MAPK was maximal at 5 min followed by a decline to basal level by 30 min. LPA also stimulated phosphorylation of Akt with kinetics similar to MAPK; however, the degree of activation as estimated by the amount of phosphorylated Akt was small as compared with MAPK. With continuous exposure of SCs to LPA, a consistent finding was a second peak of activation of MAPK and Akt at 8 and 16 h. The significance of the biphasic activation of the two kinases is unclear.
To analyze the relevant signaling pathways leading to activation of mitogen-activated protein and Akt kinases by LPA, several inhibitors were used. LPA-stimulated phosphorylation of MAPK and Akt was partially blocked by pertussis toxin, LY249002, and wortmannin but not by rapamycin (Fig. 2B) . Pretreatment of the cells with PD98059 prevented activation of MAPK while having no effect on activation of Akt (Fig. 2B) . These results, combined with the use of the same inhibitors in the SC survival assays, confirm the importance of the G ␣i / PI3K/MAPK pathway in LPA-mediated SC survival. Although MAPK activation is important for LPA-mediated SC survival, we cannot completely exclude a role for Akt in this process. ␤-Neuregulin (GGF) rescued SCs from apoptosis in an Akt-de- pendent manner (12) . However, when we compared ␤-neuregulin and LPA activation of Akt, there was significantly less activation of Akt by LPA as compared with ␤-neuregulin (Fig. 2B) .
LPA Increases Myelin Protein P 0 Expression-The LPA receptor is expressed in SC during postnatal development of peripheral nerves and parallels the formation of the myelin sheath (7) . To demonstrate a correlation between LPA signaling and myelination, we examined the effect of LPA on expression of the major myelin protein, P 0 . Western blot analysis demonstrated that LPA increased myelin P 0 protein levels within 24 h after the addition of LPA (Fig. 3A) . During normal differentiation of SCs, an increase in myelin P 0 expression is paralleled by a decrease in p75 nerve growth factor receptor expression. However, LPA did not alter the basal expression of p75 nerve growth factor receptors on SCs (data not shown). Since LPA can alter protein turnover, the increase in myelin P 0 protein may simply reflect a decrease in protein turnover. To address this question, transient transfection assays using a plasmid containing the P 0 promoter regulating expression of the bacterial CAT gene (pP 0 cat) were performed. SCs transiently transfected with pP 0 cat plasmid were treated for 24 h with LPA, at which time the cells were harvested, and CAT activity was measured. LPA increased CAT activity by 2-fold as compared with the basal expression of CAT activity (Fig. 3B) , indicating that LPA increased P 0 expression from the myelin P 0 promoter.
Edg4 Mediates LPA-induced P 0 Expression-Recent studies have identified three G protein-coupled receptors for LPA, Edg2, Edg4, and Edg7. Among them, Edg2 and Edg4 are expressed in SCs (13) . To identify the Edg receptors mediating LPA-induced P 0 expression, we carried out RNA interference study to knock down the expression of a given Edg receptor (36) . Cells were transfected with either target-specific siRNA duplexes (for Edg2 or Edg4, respectively) or a nonspecific siRNA control (GL2 luciferase siRNA duplex) (36) or buffer only. Gene silencing was measured by immunoblot analysis. In cells treated with Edg4-specific siRNA for 48 h, there was significant decrease in Edg4 protein expression (Fig. 4B) . A decrease in LPA-induced P 0 expression was also observed in cells treated with Edg4-specific siRNA (Fig. 4C) . However, no inhibition in LPA-induced P 0 expression was also observed in cells treated with Edg2-specific siRNA (Fig. 4C) , although Edg2 protein expression was down-regulated by such treatment (Fig.  4A ). These results demonstrate a role of LPA receptor Edg4 in mediating LPA induced P 0 expression.
PKC␦ Mediates P 0 Induction by LPA-To elucidate the signaling pathways through which LPA increased P 0 expression, specific inhibitors were used. Fig. 5A shows that the induction of P 0 protein expression by LPA was not inhibited by PTX (200 ng/ml). Instead, PTX enhanced LPA-induced P 0 protein levels. The Rock inhibitor Y27632 and the MEK inhibitor PD98059 both partially blocked the induction of P 0 protein expression. The broadly acting PKC inhibitor, bisindolylmaleimide II, blocked LPA-induced myelin P 0 expression. Since SCs express various isoforms of protein kinase C, more selective PKC inhibitors were used to identify the specific isoform of PKC responsible for P 0 induction (Fig. 5B) . Gö6976, an inhibitor of classical PKC␣, -␤, and -␥, had no effect on P 0 induction, whereas rottlerin, an inhibitor of PKC␦, blocked induction of P 0 by LPA. Pretreatment of SCs with 100 nM PMA (for 8 h) to down-regulate PKCs (including PKC␦) also inhibited the induction of P 0 expression by LPA (Fig. 5C) . As an index of activation, PKC␦ translocation was monitored by transfecting SCs with a plasmid carrying a DNA insert encoding for a PKC␦- 
FIG. 4. Effects of Edg2 and Edg4 siRNAs in SCs.
A, SCs were transfected with Edg2 siRNA duplex, GL2 luciferase siRNA duplex (nonspecific siRNA control), or buffer only. 48 h after transfection, Edg2 protein were assessed by Western blotting. B, SCs were transfected with Edg4 siRNS duplex, GL2 luciferase siRNA duplex (nonspecific siRNA control), or buffer only. 48 h after transfection, Edg4 protein was assessed by Western blotting. C, SCs were transfected with siRNA duplex for Edg2, Edg4, GL2 luciferase, or buffer only. 24 h after transfection, cells were treated with 10 M LPA for 24 h. P 0 protein was assessed by Western blotting. The amount of ␤-actin was used as a control of protein loading in each panel.
GFP fusion protein (30) . When transfected cells were treated with 10 M of LPA, translocation of PKC␦ to the plasma membrane was observed (Fig. 6) . To confirm the role of PKC␦ in regulating expression of P 0 in SCs, cells were infected with adenoviruses for kinase-inactive PKC␦ or PKC␣. These PKCs have been mutated in the ATP-binding site and function as dominant negative mutants (29, 30) . Infection of SCs with dominant negative PKC␦AdV dramatically decreased LPA induction of P 0 expression (Fig. 5D ). In contrast, there were no changes in LPA-induced P 0 expression in cells infected with dominant negative PKC␣AdV or control LacZAdV. Thus, it appears that the induction of P 0 expression by LPA is mainly mediated via PKC␦ and that both Rho kinase and MAPK are also likely to be involved in myelin gene expression.
LPA and Serum Stimulate Actin Stress Fiber Formation through the Rho/Rho Kinase Pathway-During differentiation, SCs undergo morphological changes and become spindleshaped. To investigate these morphological changes, the reorganization of actin cytoskeleton in SCs after serum and LPA treatment was studied. Both serum and LPA induced actin stress fiber formation within 15 min (Fig. 7, A-C) . To determine whether these changes in the actin cytoskeleton were dependent on the Rho pathway, cells were injected with C3 transferase (1 mg/ml), an enzyme that specifically inhibits RhoA by ADPribosylation of the protein (37) (Fig. 7, G and H) . Control cells were injected only with rabbit IgG (Fig. 7, E and F) . 30 min after injection, SCs were treated with 10% fetal bovine serum for 15 min. C3 transferase-injected cells failed to form stress fibers, unlike control cells injected with IgG. To further confirm a role for Rho in regulating stress fiber formation, serumstarved SCs were injected with 1 mg/ml recombinant constitutively active RhoA (V14). As expected, constitutively active RhoA rapidly increased the formation of actin stress fibers (within 15 min after injection) (Fig. 7J) . Pretreatment of Schwann cells for 30 min with 10 M Y27632, an inhibitor of Rock, a downstream target for of RhoA, blocked serum-induced (data not shown) and LPA-induced actin stress fiber formation (Fig. 7D) . Moreover, actin stress fiber formation induced by LPA was insensitive to pertussis toxin, wortmannin, PD98059, and bisindolylmaleimide II, ruling out roles for G␣ i , PI3K, MAPK, or PKC in this process (data not shown). These results indicate that both serum-and LPA-induced actin cytoskeleton reorganization in SCs are mediated by a pertussis toxin-insensitive G protein/RhoA/ROCK-dependent pathway.
DISCUSSION
During normal development and after nerve injury, SCs undergo dramatic changes in cell shape, motility, survival, and gene expression (1) . Many of these processes are tightly controlled by axons and by signals that arise from the basal lamina (3, 4, 6) . The axonal membrane provides mitogenic and differentiation signals to the SCs. Moreover, the nerve cell body and the axon secrete soluble factors that govern SC proliferation, migration, and survival. The basal lamina also provides differentiation cues to the SC. Although some of these molecules have been identified, the signal transduction pathways activated by cell surface receptors that mediate these processes are largely unknown. In SC cell culture, serum promotes cell survival and alters myelin gene expression. When we addressed the effects of serum, we found that only some were mediated by LPA. In the present work, we found that LPA exerts its effects on SC survival and differentiation using different G proteins coupled to the LPA receptor. A scheme of the pathways involved in LPA signaling is shown in Fig. 8 .
Both serum and LPA elicit antiapoptotic effects on SCs. Previously, it had been demonstrated that LPA and ␤-neuregulin mediated SC survival via a PI3K/Akt pathway (7). We find that the LPA effects on SC survival require the involvement of G␣ i , PI3K, MEK, and MAPK. Since phosphorylation of MAPK was inhibited by pretreatment of SCs with PTX or wortmannin, MAPK was downstream of G␣ i and PI3K. Additionally, the phosphorylation of Akt was also seen, albeit the extent of phosphorylation was small when compared with the robust phosphorylation of MAPK by LPA. When comparing LPA-with ␤-neuregulin-mediated SC survival, both Akt and MAPK have key roles, with PI3K having a central role. In the case of LPA-induced SC survival, we believe that G ␣i /PI3K/MAPK plays a more significant role than PI3K/Akt because of the effects of the MEK inhibitor PD98059 in abrogating the cell survival effects of LPA (Fig. 1) .
SCs in peripheral nerves are spindle-shaped, whereas in cell culture they can assume different shapes. In cell culture, differentiation of SCs is accompanied by a change in cell shape from a flat to a spindle-shaped cell. Serum or LPA treatment of SCs induces a change to spindle-shaped cell due to the reorganization of the actin cytoskeleton and the appearance of stress fibers. The stress fibers form and traverse the length of the cell in bundles. They contain F-actin, myosin, and actin-binding proteins that are anchored to the plasma membrane by focal adhesions composed of ␣-actin, vinculin, talin, and focal adhesion kinase (38) . In our studies, induction of stress fibers by RhoA in SCs was not accompanied by the appearance of focal adhesion complexes at the plasma membrane (detected by staining with anti-vinculin antiserum), probably because cells were plated on poly-L-lysine-coated coverslips. Fibroblasts under similar plating conditions are unable to form focal adhesion complexes, although they continued to form stress fibers (39) .
In fibroblasts, the reorganization of the actin cytoskeleton through Rho proteins has been extensively studied (40 -42) . LPA or serum induced stress fiber formation through a similar pathway, since activated Rho (Rho V14 ) induced formation of actin stress fibers in SCs, an effect that was mimicked by the addition of serum or LPA to these cells. Moreover, inhibiting Rho A with C3 transferase blocked serum-and LPA-induced actin changes in SCs (37) . Rho-dependent kinases (ROK␣ and p160ROCK/ROK␤) are involved in the formation of stress fibers and focal adhesions in fibroblasts (43, 44) . In our studies, LPA-induced actin stress fiber formation was prevented by the Rho kinase inhibitor Y27632. How Rho kinase participates in the reorganization of actin is unclear. It has been proposed that phosphorylation of myosin light chain phosphatase by Rho kinase may decrease phosphatase activity, thereby increasing the concentration of phosphorylated myosin light chains (42, 45 ) that bind to actin and promote formation of stress fibers (46, 47) . Alternatively, Rho kinase may induce actin stress fiber formation by promoting the bundling of preexisting filaments (41, 48) or perhaps by altering the intracellular levels of phosphatidylinositol 4,5-bisphosphate (49, 50) that causes uncapping of barbed ends of actin and thus the rapid polymerization of actin (51, 52) . LIM kinase, a substrate for p160ROCK, also FIG. 7 . LPA induces Rho-dependent actin stress fiber formation. Serum-starved SCs (A) were treated with fetal calf serum (10%) (B) and LPA (10 M) (C) for 15 min or pretreated with Y27632 (10 M) for 30 min prior to LPA treatment (D). Cells were fixed and stained with fluorescein isothiocyanate-conjugated phalloidin. Magnification was ϫ400. Serum-starved SCs were microinjected with rabbit IgG (5 mg/ml) alone (E and F) or co-injected with C3 transferase protein (1 mg/ml) and rabbit IgG (G and H). 15 min after injection, the cells were treated with fetal calf serum (10%) for 30 min. Cells were fixed and double-stained with fluorescein isothiocyanate-conjugated phalloidin (E and G) and Texas Red-conjugated donkey anti-rabbit IgG antibody (F and H) to help identify the injected cells. The arrows indicate cells injected with C3 transferase that failed to form stress fibers in response to serum (magnification, ϫ400). Serum-starved SCs were microinjected with rabbit IgG alone (I) or co-injected with RhoA V12 (1 mg/ml) (J) for 30 min. Cells were fixed and stained with fluorescein isothiocyanate-conjugated phalloidin (magnification, ϫ1000). mediates reorganization of the actin cytoskeleton (25) . However, expression of LIM kinase in SCs did not stimulate the formation of stress fibers (data not shown), suggesting that activation of LIM kinase by p160ROCK is not important in the formation of stress fibers in SCs.
In addition to morphological alterations, LPA induced the expression of myelin protein P 0 in SCs. Our siRNA experiments showed that knockdown of Edg4 expression but not Edg2 inhibited LPA-induced P 0 expression, suggesting that Edg4 mediates this effect. Interestingly, pretreatment of SCs with PTX enhanced P 0 protein expression. Since P 0 expression in SCs is stimulated by cAMP analogs and adenylyl cyclase activators, the increase in LPA-induced P 0 expression by PTX may involve an increase in intracellular cAMP levels, since G ␣i negatively regulates adenylyl cyclase.
Since changes in cell shape can influence gene expression, it was possible that LPA-induced morphological changes were sufficient to increase P 0 expression. Y27632, an inhibitor of Rho kinase, partially blocks LPA-induced expression of P 0 . Furthermore, since survival of SCs may be linked to differentiation, the effects of the MEK inhibitor PD980959 on LPA-induced expression of P 0 protein was studied. PD98059 also partially blocked this LPA effect. Finally, since LPA-mediated effects can occur via the G ␣q protein (21) , which can activate PKC, we investigated the role of PKC in P 0 expression. Several isoforms of PKC are found in SCs, including PKC␣, -␤, -⑀, and -␦ (33), and it is likely that each individual PKC isoform may have a different function in SCs. Pretreatment of SCs with bisindolylmaleimide II, a broad spectrum inhibitor of PKC, completely blocked LPAinduced expression of P 0 , indicating an important role for the PKC pathway. This was substantiated by PKC down-regulation with PMA (decreased expression of PKC␣, -␤, -⑀, and -␦ protein; data not shown), suggesting an essential role for PKCs in this effect. Gö6976, an inhibitor of "classical" PKCs (PKC␣, -␤, and -␥), had no effect on LPA induction of P 0 expression, which rules out the involvement of "classical" PKCs. However, rottlerin, a specific inhibitor for PKC␦, significantly attenuated the effect of LPA on P 0 expression. Also, overexpression of dominant negative PKC␦ in SCs inhibited LPA-induced P 0 expression, whereas dominant negative PKC␣ had no inhibitory effect. Together, these data support the concept that PKC␦ is critical in the regulation of P 0 expression by LPA.
In conclusion, our findings suggest that LPA has multiple effects on SC survival and differentiation that are mediated via coupling of the receptor to different G proteins (Fig. 8) . The survival effects are largely mediated through PI3K/MAPK, the cytoskeletal changes via RhoA, and myelin P 0 expression via PKC␦, although other pathways such as RhoA/Rock, MEK/ MAPK, and cAMP/protein kinase A are likely to play a role, indicating the complex network of pathways activated by LPA in SCs.
